Public Board of Directors papers 241122

Financial Performance Financial performance remains strong. The year-to-date position at Month 6 is a £58k surplus compared to a breakeven plan. The in-month position for month 7 is a surplus of £1k against a breakeven plan. This is in line with the annual 2022/23 revenue plan re-submitted at the end of June. This plan includes additional revenue income provided to support inflationary pressures, particularly rising energy prices, and enabled a plan to break-even overall. As shown in the table there are no significant variances from the planned financial performance against key measures. Measure of Financial Performance Red / Amber / Green rating Revenue: Trust Control Total compared to breakeven plan £58k Capital: Capital expenditure against plan 13.9% below plan CIP achieved (recurrent) against target £3.2m of £7.3m target Debtor days compared to 15-day target 8 days Cash balance £161,426k Financial details are provided in the Integrated Performance, Quality and Finance Report Responsible Executive Director – Finance Director Responsible Assurance Committee – Audit Operational Performance Overall performance remains strong apart from the 62-day referral to treatment standard. The September 62-day position has improved slightly from August to 74.5% compliance (subject to validation). We have continued to achieve the 31-day standard for treatment to start within 31 days of the decision to treat. Overall activity levels remain broadly in line with the 2022/23 plan with chemotherapy treatments, radiotherapy fractions and non-elective spells being above plan and no other significant variances. No operations were cancelled on the day for non-clinical reasons. Performance details are in the Integrated Performance, Quality and Finance Report The reported metrics confirm that the quality of care at The Christie continues to be outstanding despite the pressures of recent years. This is confirmed in the most recent CQC Insights Report (June 2022). Safer staffing numbers have met the required acuity levels to ensure appropriate levels of safety and care for our patients. Indicative staffing, in line with nursing establishments, is set to maintain a 1:6 nurse to patient ratio. On occasion this has been extended to 1:8 which is in line with recommended national staffing ratios. While we have seen an increase in patient safety incidents, following thematic review, these were not related to nurse staffing ratios. We continue to report cases of a range of infections although other than for C Difficile there are no national standards or thresholds. Although we continue to have patients with C Difficile, reflecting community prevalence of infection and the vulnerability of our patients, audits show that in no case has infection been the result of a lapse in the standards of care. There were 15 cases of hospital acquired nosocomial COVID-19 infections in October. Responsible Executive Director – Chief Operating Officer Responsible Assurance Committee – Quality Assurance Quality of Care

25